Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indonesia Set For Explosion In Number Of Hepatitis C Cases

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - The incidence of patients with hepatitis C is set to explode in Indonesia, with an estimated 7 million citizens currently infected expected to surge to 11 million people by the year 2016, according to experts at Frost & Sullivan

You may also be interested in...

Merck And Vertex Poised For Growth In Singapore's HCV Market As Medical Tourism Booms

SHANGHAI - Novel hepatitis C treatments from Merck and Vertex are expected to fare well in Singapore - with the proper marketing campaigns - due in part to increased medical tourism from neighboring Southeast Asian countries

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts